← Back to headlines
AgomAb Therapeutics (AGMB) Secures U.S. Patent for AGMB-447
AgomAb Therapeutics (AGMB) has been granted a U.S. patent for its compound AGMB-447.
12 Apr, 18:46 — 12 Apr, 18:46
Sources
Showing 1 of 1 sources
Related Stories
Moderna Raises $2 Billion via Convertible Notes for Cancer Vaccine Development
36m ago
Best Buy Raises Annual Outlook on Strong Electronics Demand
42m ago
Enbridge Partners with KKR and Apollo for C$2.7 Billion Pipeline Investment
51m ago
American Airlines Expands Transatlantic Network With New European Routes
53m ago